Blog
April 17, 2026
From genome to therapy: How HiFi long-read sequencing is helping to accelerate next-generation cancer drug research and development
Today’s cancer drug development has evolved far beyond traditional chemotherapies. Curre oncology pipeline includes precision small molecules, monoclonal antibodies, antibody-drug conjugates (ADCs), CAR-T therapies, TCR-engineered cells, and personalized cancer…
March 25, 2026
2025 Immunology and Immunotherapy SMRT Grant winners announced
Accurately capturing immune diversity is critical to advancing our understanding of disease mechanisms and enabling the development of more precise and effective therapies. However, conventional immune profiling technologies lack…
February 19, 2026
Radboud UMC research highlights promise of HiFi long-read sequencing to match standards of care in rare disease genomics
When you work in rare disease, you recognize the pattern: Test. Wait. Repeat. For families, that loop is a stretch of time that includes birthdays, school years, and treatment…